| Kevin Lienesch, DNP, CRNA | |
|
701 Lewiston St, Cottonwood, ID 83522-9750 | |
| (208) 962-3251 | |
| Not Available |
| Full Name | Kevin Lienesch |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 701 Lewiston St, Cottonwood, Idaho |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356794721 | NPI | - | NPPES |
| Entity Name | Pullman Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023676004 PECOS PAC ID: 8325374150 Enrollment ID: O20190731001913 |
News Archive
Sucampo Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, Sucampo Manufacturing & Research AG, and R-Tech Ueno, Ltd., a pharmaceutical company founded in Japan in 1989, have entered into a license agreement for RESCULA eye drops, expanding Sucampo's rights beyond its previously agreed territory of the United States and Canada to all countries in Europe and the rest of the world except Japan, Korea, Taiwan and the People's Republic of China.
Data collected in Japanese and Korean patients included in the global PALOMA3 trial provides evidence that combining palbociclib with fulvestrant is an effective strategy to overcome endocrine resistance in women with hormone receptor positive (HR+), HER2 negative (HER2-) advanced breast cancer.
A type of cell plentiful in the brain, long considered mainly the stuff that holds the brain together and oft-overlooked by scientists more interested in flashier cells known as neurons, wields more power in the brain than has been realized, according to new research published today in Science Signaling.
Scientists at the University of Michigan Medical School have identified biochemical signals that attract pathogenic cells to damaged lung tissue - one of the first steps in a chain of events leading to a lethal disease called idiopathic pulmonary fibrosis or IPF.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kevin Lienesch, DNP, CRNA Po Box 267, Grangeville, ID 83530-0267 Ph: (206) 321-6509 | Kevin Lienesch, DNP, CRNA 701 Lewiston St, Cottonwood, ID 83522-9750 Ph: (208) 962-3251 |
News Archive
Sucampo Pharmaceuticals, Inc. today announced that its wholly owned subsidiary, Sucampo Manufacturing & Research AG, and R-Tech Ueno, Ltd., a pharmaceutical company founded in Japan in 1989, have entered into a license agreement for RESCULA eye drops, expanding Sucampo's rights beyond its previously agreed territory of the United States and Canada to all countries in Europe and the rest of the world except Japan, Korea, Taiwan and the People's Republic of China.
Data collected in Japanese and Korean patients included in the global PALOMA3 trial provides evidence that combining palbociclib with fulvestrant is an effective strategy to overcome endocrine resistance in women with hormone receptor positive (HR+), HER2 negative (HER2-) advanced breast cancer.
A type of cell plentiful in the brain, long considered mainly the stuff that holds the brain together and oft-overlooked by scientists more interested in flashier cells known as neurons, wields more power in the brain than has been realized, according to new research published today in Science Signaling.
Scientists at the University of Michigan Medical School have identified biochemical signals that attract pathogenic cells to damaged lung tissue - one of the first steps in a chain of events leading to a lethal disease called idiopathic pulmonary fibrosis or IPF.
› Verified 1 days ago
Todd K. Mcallister, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 701 Lewiston St, Cottonwood, ID 83522 Phone: 208-962-3267 | |
Mr. Dennis W Tracy, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 701 Lewiston St, Cottonwood, ID 83522 Phone: 208-962-3251 Fax: 208-962-3722 |